-
Medical journals
Photodynamic Therapy as a New Prospective Method for Cancer TreatmentII. Overview of Photosensitizers
FOTODYNAMICKÁ TERAPIE JAKO NOVÁPERSPEKTIVNÍ METODA LÉČBYNÁDOROVÝCH ONEMOCNĚNÍI. PŘEHLED FOTOSENZITIZÉRŮ
Od dob zavedení derivátu hematoporfyrinu pod komerčním názvem Photofrin® do terapeuticképraxe v roce 1993 v Kanadě se značně zvýšil počet zkoumaných fotosenzitizérů (PS). Některé z nichjiž úspěšně prošly klinickými zkouškami a jsou v užívání pro léčbu jak kancerózních (ALA, temoporfin),tak nekancerózních (verteporfin) onemocnění. Jiné těmito zkouškami procházejí (talaporfin,motexafin lutecium, SnET2, ftalocyaniny). Látky novější (tzv. druhá generace), což jsou všechny PSkromě Photofrinu®, mají oproti první generaci často výhodnější vlastnosti, zejména co se týčeabsorpce při vyšších vlnových délkách, kratší kožní fotosenzitivity, lepšího poměru kumulace mezinádorovou a zdravou tkání, farmakokinetiky.
Klíčová slova:
fotodynamická terapie – fotosenzitizér – Photofrin
Authors: P. Zimčík; M. Miletín
Authors‘ workplace: Katedra farmaceutické chemie a kontroly léčiv Farmaceutické fakulty Univerzity Karlovy, Hradec Králové
Published in: Čes. slov. Farm., 2004; , 271-279
Category:
Overview
Since the time when hematoporphyrine derivative (trade name Photofrin®) has been introduced intoclinical practice in Canada in 1993, a lot of new photosensitizers (PS) have been studied. Some ofthem successfully passed the clinical trials and are in use in the treatment of cancerous (ALA,temoporfin) and non-cancerous (verteporfin) diseases. The others (motexafin lutecium, talaporfin,phthalocyanines and SnET2) are entering or passing the clinical trials now. The newer PS are alsocalled the second generation PS,when the first generation is composed of Photofrin® only.The secondgeneration PS usually possesses better properties, especially concerning absorption at longerwavelengths, shorter skin photosensitivity, better accumulation ratio between tumorous and healthytissue and pharmacokinetics.
Key words:
photodynamic therapy – photosensitizer – Photofrin
Labels
Pharmacy Clinical pharmacology
Article was published inCzech and Slovak Pharmacy
Popular this week
2004 Issue 6- Can AI Help Accelerate the Development of Antibiotics for Gonorrhea and MRSA?
- FDA Warns Against Self-Monitoring Glucose Using Smartwatches. What About in Czechia?
- Barth Syndrome Has Its First Approved Therapy — For Now Only in the U.S.
-
All articles in this issue
- Photodynamic Therapy as a New Prospective Method for Cancer TreatmentII. Overview of Photosensitizers
- Isolation of Immunoglobulins by Thiophilic Adsorption Chromatography
- Chiral Switch: Pure Enantiomers of Drugs instead of Racemic Mixtures
- Salicylanilides: Still a Topical Potential Antibacterially Active Group
- Carbomers and Their Use in Pharmaceutical Technology
- Adsorption of Substances on Active CharcoalPart 1: Basic Esters of Phenylcarbamic Acid with Local Anaesthetic Effect
- Determination of the Antioxidant Activity of Potential Scavengers of Nitrogen Oxide
- Unit Dose Systems Prepared for Geriatric Patients II
- Prescription and Structure of Formulation of Medicinal Preparations in a Pharmacy I
- Use of Chelating Extraction Membranes for the Identification and Determination ofHeavy Metals by the Method of Radionuclide X-ray Fluorescence Analysis
- Pindolol Determination in Pharmaceuticals by the Method of Capillary Isotachophoresis
- Weibull Equation and Dissolution Kinetics
- The Content of Zn and Cd in Medicinal Plants and the Dynamics of Their Transport intothe Dosage Forms
- Czech and Slovak Pharmacy
- Journal archive
- Current issue
- About the journal
Most read in this issue- Carbomers and Their Use in Pharmaceutical Technology
- Chiral Switch: Pure Enantiomers of Drugs instead of Racemic Mixtures
- Photodynamic Therapy as a New Prospective Method for Cancer TreatmentII. Overview of Photosensitizers
- Weibull Equation and Dissolution Kinetics
Enter the email address that you registered with. We will send you instructions on how to set a new password.